Creating Value For Our Shareholders

News from Bayer
September 20, 2023
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer issues 1.75 billion euro hybrid bond
September 19, 2023
Dr. Jost Reinhard appointed new head of Investor Relations at Bayer
September 18, 2023
Not intended for UK Media
Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator